Likewise, we find that IRF6 is also required for efficient TPA-induced lytic EBV reactivation in both an EBV + NPC cell line (NPC43) and an EBV+ gastric carcinoma cell line (SNU719). Here, IRF6 is linked to nasopharyngeal carcinoma.